Dyadic International (DYAI) Times Interest Earned (2018 - 2026)
Dyadic International (DYAI) posted Times Interest Earned of -$18.69 for Q1 2026, down 116.23% sequentially from $115.19 in Q4 2025, and little changed YoY from -$18.7 in Q1 2025.
Dyadic International (DYAI) Times Interest Earned (2018 - 2026) Analysis & Trends
Dyadic International has reported Times Interest Earned for 9 years, with the latest figure at -$18.69 in Q1 2026.
- Quarterly Times Interest Earned changed 0.03% year-over-year to -$18.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.5 (down 25.03% YoY) and the FY2025 annual result came in at -$0.38, down 13.11% from the prior year.
- Times Interest Earned eased to -$18.69 in Q1 2026 per DYAI's latest filing, from $115.19 in the prior quarter.
- Over five years, Times Interest Earned peaked at $115.19 in Q4 2025 and troughed at -$172.27 in Q4 2022.
- A 5-year average of -$28.34 and a median of -$9.07 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned sank 34280.76% in 2022, then soared 1267.98% in 2025.
- Over 5 years, Times Interest Earned stood at -$172.27 in 2022, then surged by 98.15% to -$3.19 in 2023, then tumbled by 209.16% to -$9.86 in 2024, then jumped by 1267.98% to $115.19 in 2025, then plunged by 116.23% to -$18.69 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$18.69, $115.19, and -$22.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | -29.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.69 |
| Dec 31, 2025 | 115.19 |
| Sep 30, 2025 | -22.41 |
| Jun 30, 2025 | -8.27 |
| Mar 31, 2025 | -18.68 |
| Dec 31, 2024 | -9.86 |
| Sep 30, 2024 | -1.76 |
| Jun 30, 2024 | -154.68 |
| Mar 31, 2024 | -98.23 |
| Mar 31, 2023 | -3.19 |
| Dec 31, 2022 | -172.27 |
| Sep 30, 2022 | -2.42 |
| Jun 30, 2022 | -0.81 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.50 |
| Sep 30, 2021 | -0.27 |
| Jun 30, 2021 | -0.65 |
| Mar 31, 2021 | -233.69 |
| Dec 31, 2020 | -0.17 |
| Sep 30, 2020 | -0.11 |